Clinical Trials Directory

Trials / Completed

CompletedNCT04557332

mHealth for ART Adherence by HIV+ African Americans

mHealth for ART Adherence by HIV+ African Americans Age 45 & Older

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
109 (actual)
Sponsor
Environment and Health Group, Inc. · Industry
Sex
All
Age
30 Years
Healthy volunteers
Not accepted

Summary

The objective of this grant is to create and test a mobile app to support ART adherence among HIV+ African American adults.

Detailed description

The Phase II project will enhance the existing (Phase 1) mobile intervention by offering: 1) a two-way communication capability through which participants can: i) indicate "pill taken" in response to pill reminders, and ii) receive a positive visual icon as behavioral-economics based reinforcement for "pill taken" responses; 2) pharmacist counseling and medication support; and, 3) the addition of educational and motivational text messages. Overall aims are to: 1) expand mhealth intervention to incorporate new Phase II features; 2) evaluate effectiveness in an RCT of HIV+ African Americans; and 3) prepare marketing and commercialization plans. Our long-term goal is to increase ART medication adherence, thus decreasing health disparities, among HIV+, African-Americans.

Conditions

Interventions

TypeNameDescription
BEHAVIORALOn the Dot Mobile appOn the Dot is a mobile app to support HIV medication adherence. The mobile app is linked to a clinician portal through which participants can receive adherence support.

Timeline

Start date
2019-04-01
Primary completion
2020-05-30
Completion
2020-05-30
First posted
2020-09-21
Last updated
2020-09-21

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04557332. Inclusion in this directory is not an endorsement.